Related references
Note: Only part of the references are listed.Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
Victor Kande Betu Ku Mesu et al.
LANCET (2018)
Seeing beyond 2020: an economic evaluation of contemporary and emerging strategies for elimination of Trypanosoma brucei gambiense
C. Simone Sutherland et al.
LANCET GLOBAL HEALTH (2017)
Improving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative Pre-Review' Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis
Carl H. Coleman et al.
Developing World Bioethics (2015)
Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies
Antoine Tarral et al.
CLINICAL PHARMACOKINETICS (2014)
A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis
Peter Babokhov et al.
PATHOGENS AND GLOBAL HEALTH (2013)
In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness
Caecilia Schmid et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
The Human African Trypanosomiasis Control and Surveillance Programme of the World Health Organization 2000-2009: The Way Forward
Pere P. Simarro et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto et al.
LANCET (2009)
Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo
Manica Balasegaram et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2006)
Clinical aspects of 2541 patients with second stage human African trypanosomiasis
J Blum et al.
ACTA TROPICA (2006)
Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: Confirmation from a multinational study (IMPAMEL II)
C Schmid et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Share Paper
